-
Je něco špatně v tomto záznamu ?
Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta-Analysis
MK. Georgakis, NG. Dimitriou, MA. Karalexi, C. Mihas, EG. Nasothimiou, D. Tousoulis, G. Tsivgoulis, ET. Petridou,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, metaanalýza, přehledy
PubMed
28152169
DOI
10.1111/jgs.14750
Knihovny.cz E-zdroje
- MeSH
- albuminurie komplikace epidemiologie moč MeSH
- demence diagnóza epidemiologie etiologie MeSH
- kognice fyziologie MeSH
- kognitivní dysfunkce etiologie MeSH
- lidé MeSH
- nemoci cév MeSH
- neuropsychologické testy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- přehledy MeSH
OBJECTIVES: Cerebral microvascular disease is considered to contribute to cognitive dysfunction. We opted to explore whether albuminuria, a marker of systemic microangiopathy, is associated with cognitive impairment, dementia, and cognitive function. DESIGN: Systematic review; independent reviewers screened 2359 articles, derived through the search strategy, for identification of observational studies quantifying an association of albuminuria with the outcomes of interest, abstracted data on study characteristics and results and evaluated studies on quality using the Newcastle-Ottawa scale. SETTING: Community. PARTICIPANTS: Adults. MESUREMENTS: Cognitive impairment and dementia, defined by validated neuropsychological tests or clinical guidelines, respectively, and cognitive function, assessed by validated instruments. RESULTS: Thirty-two eligible studies were identified. Albuminuria was associated with cognitive impairment (Odds Ratio (OR): 1.35, 95% Confidence Interval (CI): 1.19-1.53; 7,852 cases), dementia (OR: 1.35, 95% CI: 1.10-1.65; 5,758 cases), clinical Alzheimer's disease (OR: 1.37, 95% CI: 1.11-1.69; 629 cases) and vascular dementia (OR: 1.96, 95% CI: 1.16-3.31; 186 cases); the effect remained significant among longitudinal, population-based and high quality studies. Time-to-event analysis on prospective studies of non-demented at baseline individuals also showed a significant association with incident dementia (Risk Ratio: 1.52, 95% CI: 1.16-1.99; 971 cases). Worse global cognitive performance (Hedge's g: -0.13, 95% CI: -0.18, -0.09; 68,348 subjects) and accelerated cognitive decline (g: -0.20, 95% CI: -0.34, -0.07; 31,792 subjects) were noted among subjects with albuminuria, who also scored lower in executive function, processing speed, verbal fluency, and verbal memory. CONCLUSIONS: Albuminuria was independently associated with cognitive impairment, dementia and cognitive decline. The stronger effects for vascular dementia and cognitive performance in domains primarily affected by microvascular disease support that the association could be mediated by shared microvascular pathology in the kidney and the brain.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031072
- 003
- CZ-PrNML
- 005
- 20171030130802.0
- 007
- ta
- 008
- 171025s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jgs.14750 $2 doi
- 035 __
- $a (PubMed)28152169
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Georgakis, Marios K $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- 245 10
- $a Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta-Analysis / $c MK. Georgakis, NG. Dimitriou, MA. Karalexi, C. Mihas, EG. Nasothimiou, D. Tousoulis, G. Tsivgoulis, ET. Petridou,
- 520 9_
- $a OBJECTIVES: Cerebral microvascular disease is considered to contribute to cognitive dysfunction. We opted to explore whether albuminuria, a marker of systemic microangiopathy, is associated with cognitive impairment, dementia, and cognitive function. DESIGN: Systematic review; independent reviewers screened 2359 articles, derived through the search strategy, for identification of observational studies quantifying an association of albuminuria with the outcomes of interest, abstracted data on study characteristics and results and evaluated studies on quality using the Newcastle-Ottawa scale. SETTING: Community. PARTICIPANTS: Adults. MESUREMENTS: Cognitive impairment and dementia, defined by validated neuropsychological tests or clinical guidelines, respectively, and cognitive function, assessed by validated instruments. RESULTS: Thirty-two eligible studies were identified. Albuminuria was associated with cognitive impairment (Odds Ratio (OR): 1.35, 95% Confidence Interval (CI): 1.19-1.53; 7,852 cases), dementia (OR: 1.35, 95% CI: 1.10-1.65; 5,758 cases), clinical Alzheimer's disease (OR: 1.37, 95% CI: 1.11-1.69; 629 cases) and vascular dementia (OR: 1.96, 95% CI: 1.16-3.31; 186 cases); the effect remained significant among longitudinal, population-based and high quality studies. Time-to-event analysis on prospective studies of non-demented at baseline individuals also showed a significant association with incident dementia (Risk Ratio: 1.52, 95% CI: 1.16-1.99; 971 cases). Worse global cognitive performance (Hedge's g: -0.13, 95% CI: -0.18, -0.09; 68,348 subjects) and accelerated cognitive decline (g: -0.20, 95% CI: -0.34, -0.07; 31,792 subjects) were noted among subjects with albuminuria, who also scored lower in executive function, processing speed, verbal fluency, and verbal memory. CONCLUSIONS: Albuminuria was independently associated with cognitive impairment, dementia and cognitive decline. The stronger effects for vascular dementia and cognitive performance in domains primarily affected by microvascular disease support that the association could be mediated by shared microvascular pathology in the kidney and the brain.
- 650 _2
- $a albuminurie $x komplikace $x epidemiologie $x moč $7 D000419
- 650 _2
- $a kognice $x fyziologie $7 D003071
- 650 _2
- $a kognitivní dysfunkce $x etiologie $7 D060825
- 650 _2
- $a demence $x diagnóza $x epidemiologie $x etiologie $7 D003704
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a nemoci cév $7 D014652
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Dimitriou, Nikolaos G $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Karalexi, Maria A $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Mihas, Constantinos $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Internal Medicine Department, General Hospital of Kimi, Kimi, Greece.
- 700 1_
- $a Nasothimiou, Efthimia G $u Hypertension Unit and Cardiovascular Research Laboratory, First Department of Propaedeutic Internal Medicine, Laiko Hospital, Athens, Greece.
- 700 1_
- $a Tousoulis, Dimitrios $u First Department of Cardiology, School of Medicine, Hippokrateion Hospital, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Tsivgoulis, Georgios $u Second Department of Neurology, Attikon University General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Department of Neurology, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA. International Clinical Research Center, St. Anne's University Hospital in Brno, Brno, Czech Republic.
- 700 1_
- $a Petridou, Eleni Th $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- 773 0_
- $w MED00002969 $t Journal of the American Geriatrics Society $x 1532-5415 $g Roč. 65, č. 6 (2017), s. 1190-1198
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28152169 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171030130851 $b ABA008
- 999 __
- $a ok $b bmc $g 1254665 $s 992099
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 65 $c 6 $d 1190-1198 $e 20170202 $i 1532-5415 $m Journal of the American Geriatrics Society $n J Am Geriatr Soc $x MED00002969
- LZP __
- $a Pubmed-20171025